Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07163793 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Pilot Study of Reduced Venetoclax Exposure

StatusActive, Not Recruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Start date: Oct 7, 2024 to Aug 26, 2025 Completion moved earlier from Oct 2028 to Feb 2028 · Eligibility criteria expanded, about 13 words · Secondary endpoints: details revised at 3 of 10 entries Show 3 more changesShow less
    • Completion moved earlier from Oct 2028 to Feb 2028
    • Eligibility criteria expanded, about 13 words
    • Secondary endpoints: details revised at 3 of 10 entries
  2. Enrollment closed, study ongoing Eligibility criteria shortened, about 72 words · Site details revisedv4 Show 2 more changesShow less
    • Eligibility criteria shortened, about 72 words
    • Site details revised

    See this version in full on ClinicalTrials.gov ↗

  3. Site contact updatedv3
  4. Study description expanded, about 133 wordsv2 See this version in full on ClinicalTrials.gov ↗
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Pilot Study of Reduced Venetoclax Exposure
Trial Details
NCT Number NCT07163793
Lead Sponsor Northwell Health
Conditions Acute Myeloid Leukemia in Remission
Enrollment 41 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov